S 4321
Alternative Names: PD-1-FcγRIIb; S-4321Latest Information Update: 15 Jan 2024
At a glance
- Originator Seismic Bio
- Class Bispecific antibodies
- Mechanism of Action Fc gamma receptor IIB modulators; Programmed cell death 1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Autoimmune disorders
Most Recent Events
- 04 Dec 2023 Preclinical trials in Autoimmune disorders in USA (Parenteral)
- 04 Dec 2023 Pharmacodynamics data from a preclinical studies in Autoimmune disorders released by Seismic Therapeutic (Seismic Therapeutic pipeline, December 2023)
- 04 Dec 2023 Seismic Therapeutic plans a phase I trial for Autoimmune disorders